Robert J. Mears - 01 Mar 2022 Form 4 Insider Report for Atomera Inc (ATOM)

Signature
/s/ Mindi Zimmer as Attorney in Fact For: Robert Mears
Issuer symbol
ATOM
Transactions as of
01 Mar 2022
Transactions value $
-$167,946
Form type
4
Filing time
03 Mar 2022, 15:03:14 UTC
Previous filing
25 Feb 2022
Next filing
03 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATOM Common Stock Options Exercise $70.1K +10K +7.85% $7.01 137K 01 Mar 2022 Direct F1
transaction ATOM Common Stock Sale -$162K -10K -7.28% $16.17 127K 01 Mar 2022 Direct F2
transaction ATOM Common Stock Sale -$8.57K -537 -0.42% $15.95 127K 01 Mar 2022 Direct F3
transaction ATOM Common Stock Sale -$8.87K -556 -0.44% $15.95 126K 01 Mar 2022 Direct F3
transaction ATOM Common Stock Sale -$1.87K -117 -0.09% $15.95 126K 01 Mar 2022 Direct F3
transaction ATOM Common Stock Sale -$14.6K -917 -0.73% $15.95 125K 01 Mar 2022 Direct F3
transaction ATOM Common Stock Sale -$42.4K -2.8K -2.24% $15.15 122K 01 Mar 2022 Direct F2
holding ATOM Common Stock 2.67K 01 Mar 2022 by Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATOM Employee Stock Option (right to buy) Options Exercise $0 -10K -9.92% $0.00 90.8K 01 Mar 2022 Common Stock 10K $7.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and exercised from a previously reported total.
F2 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F3 Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants that were previously reported. This sale is to satisfy mandatory non-discretionary tax withholding obligations by a "sell to cover" transaction.